Age-related macular degeneration and cardiovascular disease in the era of anti-vascular endothelial growth factor therapies.
Publication
, Journal Article
Wong, TY
Published in: Am J Ophthalmol
September 2009
Duke Scholars
Published In
Am J Ophthalmol
DOI
EISSN
1879-1891
Publication Date
September 2009
Volume
148
Issue
3
Start / End Page
327 / 329
Location
United States
Related Subject Headings
- Vascular Endothelial Growth Factor A
- Risk Factors
- Ophthalmology & Optometry
- Macular Degeneration
- Humans
- Cardiovascular Diseases
- Angiogenesis Inhibitors
- 1117 Public Health and Health Services
- 1113 Opthalmology and Optometry
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Wong, T. Y. (2009). Age-related macular degeneration and cardiovascular disease in the era of anti-vascular endothelial growth factor therapies. Am J Ophthalmol, 148(3), 327–329. https://doi.org/10.1016/j.ajo.2009.05.012
Wong, Tien Y. “Age-related macular degeneration and cardiovascular disease in the era of anti-vascular endothelial growth factor therapies.” Am J Ophthalmol 148, no. 3 (September 2009): 327–29. https://doi.org/10.1016/j.ajo.2009.05.012.
Wong TY. Age-related macular degeneration and cardiovascular disease in the era of anti-vascular endothelial growth factor therapies. Am J Ophthalmol. 2009 Sep;148(3):327–9.
Wong, Tien Y. “Age-related macular degeneration and cardiovascular disease in the era of anti-vascular endothelial growth factor therapies.” Am J Ophthalmol, vol. 148, no. 3, Sept. 2009, pp. 327–29. Pubmed, doi:10.1016/j.ajo.2009.05.012.
Wong TY. Age-related macular degeneration and cardiovascular disease in the era of anti-vascular endothelial growth factor therapies. Am J Ophthalmol. 2009 Sep;148(3):327–329.
Published In
Am J Ophthalmol
DOI
EISSN
1879-1891
Publication Date
September 2009
Volume
148
Issue
3
Start / End Page
327 / 329
Location
United States
Related Subject Headings
- Vascular Endothelial Growth Factor A
- Risk Factors
- Ophthalmology & Optometry
- Macular Degeneration
- Humans
- Cardiovascular Diseases
- Angiogenesis Inhibitors
- 1117 Public Health and Health Services
- 1113 Opthalmology and Optometry
- 1103 Clinical Sciences